Postdoc Matthew Applegate Awarded F32 Fellowship from NIBIB
Postdoc Matthew Applegate was recently awarded an NIH F32 Fellowship form the NIBIB for his project: “Diffuse Optical B-scan Imaging (DOBI) for Breast Cancer Monitoring”
Postdoc Matthew Applegate was recently awarded an NIH F32 Fellowship form the NIBIB for his project: “Diffuse Optical B-scan Imaging (DOBI) for Breast Cancer Monitoring”
Tech Reporter Janet Morrissey wrote a nice piece for the NYTs that included a discussion of the BOTLab’s wearable chemotherapy monitoring probe: Looking to Technology to Avoid Doctors’ Offices and Emergency Rooms
The Boston Business Journal published an article on BOTLab’s wearable probe technology: Life-saving snapshot: BU-developed device gives real-time data on tumors
4th section in the article, entitled: “A Fitbit for cancer”
Darren Roblyer was interviewed about BOTLab research by Kim Carrigan for her YourHealthyLife Podcast (on iHeartRadio). note: you’ll need to sign in or create an iHeartRadio account to listen
The BOSTON BIOMEDICAL INNOVATION CENTER has awarded the BOTLab a pilot grant to accelerate our ultra-fast frequency domain diffuse optical technology towards commercialization
The ACS has awarded the BOTLab a new Mission Boost grant to move our wearable breast cancer probe to the clinic. See more about the Mission Boost Mechanism here: https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/mission-boost-grants.html
See this great article about our wearable tech on the ACS website https://www.cancer.org/latest-news/new-device-aims-to-use-light-to-predict-how-well-chemotherapy-treats-breast-cancer.html
Fei Teng (ECE) successfully defended his Ph.D. on August 9th!
Yanyu Zhao successfully defended his Ph.D. on July 10. Congratulations to Yanyu! Yanyu is staying with the BOTLab as a postdoc in the near-term.